Physician profile
Sara K Herrera
NPI 1235412917
$8,758.31
in general payments reported to CMS, 2019-2025
8 companies · $15.87 in 2025
The $15.87 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,877 · 2022: $1,608 · 2023: $257 · 2025: $15.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,924.35 | 2021-2023 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,496.08 | 2022 | |
| Innovation Technologies INC | $106.36 | 2023 | Irrisept |
| Shockwave Medical, INC | $73.42 | 2021 | |
| Kci USA, INC. | $55.57 | 2023 | Prevena |
| Abbott Laboratories | $44.87 | 2022-2023 | Cardiomems |
| Integra Lifesciences Corporation | $41.79 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $15.87 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Herrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.